Ashland Global Holdings Inc. offers specialized chemical solutions globally. The company is headquartered in Covington, Kentucky.
| Revenue (TTM) | $1.81B |
| Gross Profit (TTM) | $602.00M |
| EBITDA | $343.00M |
| Operating Margin | 10.60% |
| Return on Equity | -31.00% |
| Return on Assets | 1.99% |
| Revenue/Share (TTM) | $39.74 |
| Book Value | $40.75 |
| Price-to-Book | 1.63 |
| Price-to-Sales (TTM) | 1.72 |
| EV/Revenue | 2.309 |
| EV/EBITDA | 20.71 |
| Quarterly Earnings Growth (YoY) | -47.50% |
| Quarterly Revenue Growth (YoY) | 0.60% |
| Shares Outstanding | $45.79M |
| Float | $41.05M |
| % Insiders | 1.16% |
| % Institutions | 112.97% |
Volatility is currently contracting
Ashland NYSE: ASH reported higher sales across all four business units in its fiscal third quarter of 2026, supported by volume growth, pricing actions and demand in its Life Sciences and Personal Care operations. The company reaffirmed its full-year sales and adjusted EBITDA outlook, while lowering its adjusted earnings-per-share growth forecast because of a higher tax rate tied to unfavorable discrete items.
ASH's Q3 sales beat estimates as volume growth lifted all segments, but adjusted earnings missed and the company lowered its fiscal 2026 EPS growth outlook.
Ashland (ASH) came out with quarterly earnings of $1.02 per share, missing the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $1.04 per share a year ago.
Sales of $497 million, up seven percent from the prior-year quarter Income from continuing operations of $41 million, or $0.89 per diluted share Adjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $47 million, or $1.02 per diluted share Net income of $16 million, or $0.35 per diluted share Sales volumes rose six percent from the prior-year quarter, with gains achieved across all business units Adjusted EBITDA of $109 million, down four percent from the prior-year quarter, primarily reflecting growth in Life Sciences and Personal Care, more than offset by lower Specialty Additives and Intermediates earnings Cash flows provided by operating activities of $121 million; Ongoing Free Cash Flow2 of $103 million Reaffirming full‑year fiscal 2026 sales guidance of $1,835-$1,870 million and Adjusted EBITDA guidance of $385-$400 million WILMINGTON, Del., July 28, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced financial results1 for the third quarter of fiscal year 2026, which ended June 30, 2026, and reaffirmed its full-year fiscal 2026 sales and Adjusted EBITDA outlook.
WILMINGTON, Del., July 28, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), a global leader in additives and specialty ingredients, today announced the appointments of two new independent members of the Company Board of Directors and the formation of a Capital Allocation Advisory Committee as part of entry into a cooperation agreement with Ancora Holdings Group, LLC, a meaningful stockholder.
Ashland (ASH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WILMINGTON, Del., July 14, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its third-quarter fiscal 2026 earnings release at approximately 5 p.m.
AOS, APOG and ASH have been added to the Zacks Rank #5 (Strong Sell) List on June 10, 2026.
Ashland (ASH) reported earnings 30 days ago. What's next for the stock?
BKR, ASH and AB have been added to the Zacks Rank #5 (Strong Sell) List on May 28, 2026.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ASH and any ticker you trade — then tracks every position and per-strategy win rate.
